Lasa Supergenerics Limited has informed the Exchange regarding Resignation of Ms Manali Bhagtani as Non- Executive Independent Director of the company w.e.f. July 31, 2025.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics has informed exchanges that Ms. Manali Bhagtani (DIN: 08067867) has resigned as Non-Executive Independent Director effective July 31, 2025. This is a revised disclosure submitted under Regulation 30 of SEBI LODR. In her resignation letter, she stated the reason as the 'non-operational status of the company and lack of active business operations,' which limits her ability to contribute meaningfully as a board member. She confirmed there are no other material reasons for stepping down. The company has attached her resignation letter and full disclosure details as required under SEBI's July 13, 2023 circular.
This is a notable red flag for shareholders — an independent director publicly resigning due to the company being non-operational and lacking business activity raises serious governance concerns. Investors should treat this as a warning sign about the company's operational health, and may want to seek clarification from the board on the company's current business status, revival plans, and any plans to induct a replacement director.